Results 271 to 280 of about 1,322,584 (361)

Substance-Specific Treatment Responses and Resistance Patterns in Induced Psychoses: A Scoping Review of Antipsychotic Efficacy. [PDF]

Healthcare (Basel)
Ricci V, Chiappini S, Martinotti G, Maina G.   +3 more
europepmc   +1 more source

Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States

Arthritis Care &Research, EarlyView.
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley   +1 more source

Sex differences in reward network activation are linked to problematic substance use among high-risk adolescents. [PDF]

Adv Drug Alcohol Res
Murray OK, Mattey-Mora PP, Aloi J, Lovins S, Smoker MP, Hulvershorn LA.   +5 more
europepmc   +1 more source

Arts therapies methods in the treatment of eating disorders and other substance – related and addictive disorders

, 2016
Ana Hram
openalex   +1 more source

Lived and Care Experiences of Chronic Musculoskeletal Shoulder Pain in Australian Adults: A Qualitative Study

Arthritis Care &Research, EarlyView.
Objective Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centered care and informing local service pathways and care guidelines or standards.
Sonia Ranelli, Joanne E. Jordan, Ilana N. Ackerman, Alison Thorpe, Jennifer G. Persaud, Linda J. Woodhouse, Jason Chua, Ben Horgan, Andrew M. Briggs   +8 more
wiley   +1 more source

Identifying psychiatric morbidity and comorbidity patterns associated with COVID-19 mortality. A register-based cohort study from Catalonia. [PDF]

Eur Psychiatry
Felez-Nobrega M, Giné-Vázquez I, Monistrol-Mula A, Melchior M, Hecker I, Mittendorfer-Rutz E, Gémes K, Lora A, Caggiu G, Monzio M, Conflitti C, Sijbrandij M, Witteveen A, Haro JM.   +13 more
europepmc   +1 more source

A Moderated Mediation Model of Age-Related Decline in Selective Executive Functions and Quality of Life in Men with Substance Use Disorder.

Shameem Fatima, Sajid Hassan, Farhat Jameel   +2 more
openalex   +2 more sources

LOXHD1 and RHOB Expression by Monocytes Predicts Progressive Systemic Sclerosis associated Interstitial Lung Disease

Arthritis Care &Research, Accepted Article.
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla, Robert Lafyatis, Kevin F Gibson, Christina Morse, Eleanor Valenzi, Xiaoping Chen, Xiaoyun Li, Yanwu Zhao, Yongseok Park, Dana Ascherman, Jonathan Minden, Robyn Domsic, Yingze Zhang, Daniel J Kass   +13 more
wiley   +1 more source

Actigraphy-based sleep outcomes in substance use disorders: A protocol for a systematic review and meta-analysis. [PDF]

PLoS One
Paredes Naveda AM, Oliva HNP, Ghadimi DJ, Angarita GA.   +3 more
europepmc   +1 more source

P-1281. A Novel Substance Use Disorder-Focused Infectious Diseases Consultation Service: Our Experience with Xylazine-Related Ulcers

Elizabeth Novick, Carolyn D. Kramer, John Zurlo, Dagan Coppock, Nikhil Seval, Mollie Tucker   +5 more
openalex   +1 more source